Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Anticancer Activity of Metallodrugs

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Jul 31, 2024 3:56pm

162 Views

Post# 36156877

RE:RE:Anticancer Activity of Metallodrugs

Xrays ARE photons, they are high energy photons (or high frequency light waves if you like).They dont "turn" into photons. They may certainly lose energy as they pass through tissue though, and in doing so be reduced to microwaves or some other lower energy/lower frequency component of the light spectrum

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)